New York State Common Retirement Fund
CERE

New York State Common Retirement Fund’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

New York State Common Retirement Fund’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,604
Closed -$1.62M – 3405
2024
Q2 		$1.62M Buy
39,604
+11,025
+39% +$459K ﹤0.01% 1546
2024
Q1 		$1.21M Buy
28,579
+44
+0.2% +$1.85K ﹤0.01% 1690
2023
Q4 		$1.21M Buy
28,535
+1,383
+5% +$39.7K ﹤0.01% 1698
2023
Q3 		$593K Buy
27,152
+207
+0.8% +$5.18K ﹤0.01% 1983
2023
Q2 		$857K Sell
26,945
-3,542
-12% -$109K ﹤0.01% 1848
2023
Q1 		$744K Sell
30,487
-10,684
-26% -$314K ﹤0.01% 1970
2022
Q4 		$1.3M Buy
41,171
+19
+0% +$536 ﹤0.01% 1841
2022
Q3 		$1.16M Buy
41,152
+3,146
+8% +$93.7K ﹤0.01% 1894
2022
Q2 		$1M Buy
38,006
+7,552
+25% +$214K ﹤0.01% 2012
2022
Q1 		$1.07M Buy
30,454
+1,928
+7% +$56.3K ﹤0.01% 2076
2021
Q4 		$925K Buy
28,526
+3,059
+12% +$108K ﹤0.01% 2138
2021
Q3 		$751K Sell
25,467
-4,733
-16% -$133K ﹤0.01% 2248
2021
Q2 		$774K Buy
+30,200
New +$432K ﹤0.01% 2348

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

New York State Common Retirement Fund's CERE Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 39,604 shares — an estimated $1.62M sold.

New York State Common Retirement Fund first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $1.62M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 39,604 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.62M.
  • New York State Common Retirement Fund first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • New York State Common Retirement Fund's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.62M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.